Pieris Pharmaceuticals, Inc. Made Big Gain
Wed, Jul 24, 2024 at 07:09 PM
Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ) rocketted at $15.05, representing a gain of 89.5%. On Wed, Jul 24, 2024, PIRS:NASDAQ hit a New 2-Week High of $15.05. The stock appeared on our News Catalysts scanner on Wed, Jul 24, 2024 at 07:18 AM in the 'AGREEMENT' category. From Wed, Jul 10, 2024, the stock recorded 70.00% Up Days and 45.45% Green Days
About Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ)
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 105.38%
- Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ), 89.55%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Selina Hospitality PLC (SLNA:NASDAQ), 75.77%
- QXO Inc Com Par Value $0.00001 (New) (QXO:NASDAQ), 56.32%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 39.55%
- SCWorx Corp. (WORX:NASDAQ), 39.13%
- KORE Group Holdings Inc. (KORE:NYSE), 33.48%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 31.77%